This was consistent with the findings in a matched case-control study of 143 CKD patients suggesting that higher NGAL levels, but not KIM-1 levels, were associated with incident CKD stage 3 (Bhavsar et al., 2012). The gene discussed is LCN2; the disease is chronic kidney disease.